Aspirin for prevention of cardiovascular events
Hiatt, W.R.
Bmj 337: A1806
2008
ISSN/ISBN: 0959-8138 PMID: 18927172 Document Number: 621281
Document emailed within 1 workday
Related Documents
Guo, Y.F. 2019: Effects of aspirin on primary prevention of cardiovascular events in patients with hypertension Zhonghua Nei Ke Za Zhi 58(4): 249-251Iavelov, I.S. 2006: Aspirin in primary prevention of cardiovascular events in women and men (a meta-analysis of randomized controlled trials) Kardiologiia 46(3): 75-76
Gaciong, Z. 2006: Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study Kardiologia Polska 64(5): 548
Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
Mallonee, S.; Daniels, C.G.; Mold, J.W.; Cline, T.L. 2010: Increasing aspirin use among persons at risk for cardiovascular events in Oklahoma Journal of the Oklahoma State Medical Association 103(7): 254-260
Mutter, J.; Grandy, R.; Hulkower, S.; Stigleman, S. 2018: Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events? Journal of Family Practice 67(4): 247-248
Kalantzi, K.I.; Ntalas, I.V.; Chantzichristos, V.G.; Tsoumani, M.E.; Adamopoulos, D.; Asimakopoulos, C.; Bourdakis, A.; Darmanis, P.; Dimitriadou, A.; Gkiokas, S.; Ipeirotis, K.; Kitikidou, K.; Klonaris, I.; Kostaki, A.; Logothetis, D.; Mainas, K.; Mais, T.; Maragiannis, A.; Martiadou, K.; Mavronasos, K.; Michelongonas, I.; Mitropoulos, D.; Papadimitriou, G.; Papadopoulos, A.; Papaioakeim, M.; Sofillas, K.; Stabola, S.; Stefanakis, E.; Stergiou, D.; Thoma, M.; Zenetos, A.; Zisekas, S.; Goudevenos, J.A.; 2019: Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial Current Vascular Pharmacology 17(6): 635-643
Stalnikowicz-Darvasi, R. 1995: Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis Journal of Clinical Gastroenterology 21(1): 13-16
Kulbertus, H. 2005: Aspirin and cardiovascular prevention: last minute information Revue Medicale de Liege 60(3): 198-200
Miser, W.Fred. 2011: Appropriate aspirin use for primary prevention of cardiovascular disease American Family Physician 83(12): 1380-1386
Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease Bmj 324(7342): 917
Fichet, Jérôme.; Bressolle, C. 2009: Telmisartan for prevention of cardiovascular events New England Journal of Medicine 360(3): 302-303; Author Reply 303
Owens, D.K. 2017: Aspirin for the Prevention of Cardiovascular Disease and Colorectal Cancer: New Recommendations from the USPSTF American Family Physician 95(4): 222-223
De Caterina, R. 2003: Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(4): 228-231
Rocha, E.; Mello e Silva, A.; Nogueira, P. 2003: Relation between hypertension and cardiovascular events--implications for coronary prevention Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 22(10): 1215-1224
Maciá Bobes, C.; Ronzón Fernández, Aánzazu.; Fernández García, E. 2007: Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA? Atencion Primaria 39(3): 163-164
Nordt, T. 2001: Primary prevention of cardiovascular events by ASS and vitamin E. PPP--Primary Prevention Project Der Internist 42(12): 1705-1707
Klomp, C.M.C.; ten Cate, H.; Stehouwer, C.D.A.; Schaper, N.C. 2009: Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events Nederlands Tijdschrift Voor Geneeskunde 153: A109
Nilsson, P.M.; Håkansson, J. 2005: Amlodipine better than atenolol in hypertension. More efficient prevention of the mortality and cardiovascular events according to the ASCOT trial Lakartidningen 102(41): 2922-2923
De Caterina, R. 2001: The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 2(6): 681-684